MBX
MBX Biosciences, Inc.
53.60$
-3.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 99.2% | 96.5% | 93.5% | 99.6% | 99.5% | 99.3% | 99.0% | 99.4% | 99.1% | 99.1% | 98.2% | |
| – | 36.3% | 47.0% | 19.9% | 47.0% | 18.4% | 12.2% | 17.2% | 55.8% | 19.5% | 10.0% | 12.4% | |
| – | 95.8% | 93.4% | 87.9% | 98.1% | 97.6% | 97.9% | 97.1% | 97.9% | 97.0% | 97.2% | 96.0% | |
| – | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | 0.6% | 0.4% | 0.4% | 0.6% | 0.7% | 0.7% | |
| – | – | 0.0% | – | – | – | – | – | – | – | – | – | |
| – | 186.1% | 8.0% | 255.7% | 3.9% | 4.1% | 4.3% | 5.3% | 3.1% | 4.1% | 3.3% | 6.0% | |
| – | 4.7% | 7.6% | 13.0% | 3.9% | 4.1% | 4.3% | 5.1% | 3.0% | 4.0% | 3.2% | 5.4% | |
| – | 0.2% | 0.2% | 0.3% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.1% | |
| – | 1.7% | 4.2% | 5.1% | 1.8% | 2.0% | 1.7% | 2.5% | 0.9% | 0.8% | 1.5% | 1.0% | |
| – | -86.1% | 92.0% | -155.7% | 96.1% | 95.9% | 95.7% | 94.7% | 96.9% | 95.9% | 96.7% | 94.0% | |
| – | -89.8% | -116.7% | -165.0% | -43.2% | -51.2% | -65.6% | -78.1% | -50.6% | -58.3% | -54.8% | -65.4% | |
| – | 37.8% | 44.3% | 53.1% | 11.8% | 12.4% | 13.6% | 14.4% | 8.5% | 9.5% | 10.3% | 10.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.